Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 7, 2023; 29(21): 3302-3317
Published online Jun 7, 2023. doi: 10.3748/wjg.v29.i21.3302
Table 5 Comparison of clinicopathological parameters between two groups
Project
Wild-type (n = 19)
Mutant-type (n = 73)
P value
Gender
Male11440.851
Female829
Family history
No13510.903
Yes622
ABO blood group1
A7230.964
B621
AB418
O29
Rh blood group1
Negative00
Positive1971
Age of initial treatment (years)18.474 ± 8.808912.973 ± 8.38810.021
Final age of follow-up (years)30.842 ± 11.310127.425 ± 9.76800.239
Total hospitalizations3 (1, 4)4 (3, 6)0.003
Age of first intussusception (years)22 (14, 27) 15 (9.25, 24) 0.025
Frequency of intussusception1 (1, 2) 2 (1, 3) 0.006
Age of initial surgery (years)19 (14, 25)14 (8, 23.75) 0.007
Number of operations1 (1, 2)1 (1, 2)0.924
Age of mucocutaneous pigmentation appearance (years)3 (0, 5) 3 (0.5, 5) 0.811
Order of mucocutaneous pigmentation appearance
Lips2170.213
Lips and limbs146
Lips to limbs1610
Time interval from mucocutaneous pigmentation appearance to abdominal symptoms (years)14.5 (8, 25.5)10 (5, 15) 0.038
Distribution of gastric polyps
Yes16 (84.2%) 60 (82.2%)1
No3 (15.8%) 13 (17.8%)
Load of gastric polyps5 (5, 10) 5 (3.25, 10) 0.111
Maximum diameter of gastric polyps (mm)7 (4.25, 10) 10 (6, 15) 0.012
Distribution of duodenal intestine polyps
Yes18 (94.7%) 71 (97.3%) 1
No1 (5.3%) 2 (2.7%)
Load of duodenal intestine polyps3 (1, 6.5) 7 (4, 15.5) 0.013
Maximum diameter of duodenal intestine polyps (mm)30 (15, 50) 48 (30, 60) 0.110
Distribution of colorectal polyps
Yes6 (31.6%) 52 (71.2%) 0.001
No13 (68.4%) 21 (28.8%)
Load of colorectal polyps4 (1.5, 12) 3 (1, 10) 0.864
Maximum diameter of colorectal polyps (mm)30 (15, 50) 25 (13.5, 40) 0.664
Carcinogenesis
Yes0 (0%) 9 (9.52%) 0.239
No19 (100%) 64 (90.48%)
Pathology of polyps
Hamartoma12350.344
Adenoma28
Hamartoma + adenoma24
Carcinogenesis09
Deletion317
Times of endoscopic examinations2 (1, 2)2 (2, 4.75)0.012